KDM6B and Hodgkins lymphoma: KDM6B is overexpressed in a variety of blood disorders, including myelodysplastic syndromes, M5 acute myeloid leukemia, Hodgkin’s lymphoma, multiple myeloma, and T cell acute lymphoblastic leukemia (56–60).